Peter C. Black

1. Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605
   2023/08/16 by Peter C. Black, Catherine M. Tangen, Parminder Singh +13 · 2 citations
   Immunology and Microbiology · Medicine · #Bladder and Urothelial Cancer Treatments #Immune responses and vaccinations #Urinary and Genital Oncology Studies
2. Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer
   2014/10/01 by Luuk van Hooren, Linda C. Sandin, Igor Moskalev +7 · 25 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Biology #Bladder and Urothelial Cancer Treatments #Bladder cancer #CTLA-4 #Cancer #Cancer Immunotherapy and Biomarkers #Cancer research #Diabetes and associated disorders #Genetics #Immune cells in cancer #Immune system #Immunology #Pharmacology #T cell
3. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
   2023/05/16 by Ibrahim Jubber, Sean Ong, Laura Bukavina +17 · 2 citations
   Environmental Science · Medicine · #Bladder and Urothelial Cancer Treatments #Health, Environment, Cognitive Aging #Urinary Tract Infections Management